St. Jude Device to Close Heart Holes Fails to Stop Stroke
This article is for subscribers only.
St. Jude Medical Inc.’s device to plug openings in the heart after a stroke failed to definitively prevent repeat incidents in patients under age 60 compared with non-surgical drug treatment, two studies found.
The data calls into question broader use of the procedure and the product, used for nearly two decades at a cost of about $20,000 for each of about 9,000 surgeries done yearly.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
St. Jude Device to Close Heart Holes Fails to Stop Stroke